Study shows importance of cause of kidney failure when planning future treatment

June 22, 2015, Stanford University Medical Center

As a new physician in Galway, Ireland, and then as a nephrology fellow at the Stanford University School of Medicine, Michelle O'Shaughnessy, MD, began to wonder whether similar treatment plans for all patients whose kidneys had failed was necessarily the best practice.

"I was struck by my patients, who were often young and on dialysis at the age of 23 or 24," O'Shaughnessy said, referring to patients whose kidneys had failed because of glomerulonephritis, a group of rare disorders that damage the kidney's ability to filter the blood.

"I thought there should be other avenues for them," she added. "They were trying to get a career going, to keep their life together. We should be able to treat them better."

Currently, the standard of care is to follow a similar treatment plan for most kidney-failure patients, whatever the initial cause of their kidney failure. The two leading causes in the United States are hypertension and diabetes, followed by the rarer glomerulonephritis, which is also called glomerular disease.

"The cause of the kidney failure and the of prior treatments are often disregarded," O'Shaughnessy said. "All these patients receive the same kind of generic treatment approach: a transplant or dialysis. The original cause of kidney failure is not usually taken into account."

O'Shaughnessy set out to research whether it might be more beneficial to tailor treatment plans individually for kidney failure patients. For example, a patient with a high risk for infections may benefit from a certain type of vascular access for dialysis, or a patient at increased risk for cancer may benefit from more regular cancer screening before and after .

Subtype of disease matters

In a resulting study, published online June 19 in the Clinical Journal of the American Society of Nephrology, O'Shaughnessy and colleagues used big data to determine that mortality rates for patients whose kidney failure was attributed to glomerulonephritis vary significantly according to which subtype of the disease they had. These results suggest that treatment plans should vary according to root causes of kidney failure, she said.

"We showed that a patient's cause of kidney failure is strongly associated with their risk of dying after starting dialysis or receiving a kidney transplant," she said. "This suggests that the cause of kidney failure should not be forgotten even after a patient's kidneys fail; instead, treatment should be tailored toward disease-specific risks, and research should be carried out to determine why these survival disparities exist."

Researchers examined data from 84,301 patients who, between 1996 and 2011, suffered end-stage kidney disease attributed to one of the six major glomerular disease subtypes.

"We followed these patients to see what their survival was like," O'Shaughnessy said. "We observed quite significant differences in survival."

Results showed that the specific type of glomerular disease determined how long a patient lived after developing kidney failure. For example, mortality ranged from 4 percent per year for patients with the subtype IgA nephropathy to 16 percent per year for patients with the subtype vasculitis. After adjusting for various differences among patients—such as their age, whether they had diabetes or had received a kidney transplant—the researchers found that patients with lupus nephritis were almost twice as likely to die as patients with IgA nephropathy.

"When you divide patients according to their glomerular disease subtype, you actually see a whole spectrum of outcomes," O'Shaughnessy said.

Kidney failure in children

Glomerulonephritis is the leading cause of kidney failure in children. It is most commonly an autoimmune disease that is characterized by inflammation of the glomeruli, tiny blood vessels in the kidneys that remove waste and excess fluids from the body. But each of the many glomerular disease subtypes is unique. In certain subtypes, the immune system attacks the kidneys; in others, it damages the blood vessels.

As a result, the various subtypes are treated using different methods before the kidneys begin to fail. The treatments may include steroids or stronger immunosuppressant medications. The resulting side effects can range from severe infections to diabetes to cancer.

"The rest of the body, apart from the kidneys, has had different degrees of damage from the disease itself and the types of treatments it has undergone prior to kidney failure," O'Shaughnessy said. "When the patients get to dialysis or have a , it's still important for us to remember that"—and to treat accordingly.

O'Shaughnessy thought about this when she was making her rounds as a new physician caring for young patients on dialysis.

"It occurred to me that when I saw those patients, they weren't telling me how they're worried about the fact that they've got glomerular disease," she said. "When I saw them at the clinic or at the dialysis center, they were bothered by the fact that they were getting infections or cancer, or developing other side effects from their medications."

It's important to know why one kidney patient does well and another does poorly, she said. If physicians take into consideration what caused the kidneys to fail in the first place and what types of treatments patients received prior to , it could possibly improve the ' quality of life or increase their life span, she added.

Wolfgang Winkelmayer, MD, a former Stanford faculty member who is now professor of nephrology at Baylor College of Medicine, is senior author of the study. Other Stanford authors are Maria Montez-Rath, PhD, research associate, and Richard Lafayette, MD, associate professor of nephrology.

Explore further: Hospitalizations for heart failure increase CKD patients' risk of kidney failure

Related Stories

Hospitalizations for heart failure increase CKD patients' risk of kidney failure

September 4, 2014
Being hospitalized for heart failure increases kidney disease patients' risks of developing kidney failure or dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of ...

Measuring kidney health could better predict heart disease risk

May 29, 2015
Simple measures of kidney function and damage may be just as good at predicting who is at risk for heart failure and death from heart attack and stroke as traditional tests of cholesterol levels and blood pressure, new Johns ...

Kidney patients living longer on dialysis, study shows

March 27, 2015
(HealthDay)—New statistics suggest that kidney patients on dialysis are surviving longer.

A high acid diet may have negative effects on kidney health

February 12, 2015
For patients with chronic kidney disease, diets with a high acid content may increase their risk of developing kidney failure. The finding, which comes from a study appearing in an upcoming issue of the Journal of the American ...

Heart failure drugs beneficial even in presence of kidney disease

May 25, 2015
A novel study from Karolinska Institutesuggests that RAS-antagonists, common drugs for patients with heart failure, may benefit also patients who have concomitant kidney disease, a group previously not studied.

Rapid testing for gene variants in kidney donors may optimize transplant outcomes

March 24, 2015
Kidney transplantation outcomes from deceased African-American donors may improve through rapid testing for apolipoprotein L1 gene (APOL1) renal risk variants at the time of organ recovery, according to a new study led by ...

Recommended for you

Study reveals new therapeutic target for slowing the spread of flu virus

June 22, 2018
Influenza A (flu A) hijacks host proteins for viral RNA splicing and blocking these interactions caused replication of the virus to slow, according to new research published in Nature Communications by Kristin W. Lynch, Ph.D., ...

First ancient syphilis genomes decoded

June 21, 2018
An international research team, including scientists from the Max Planck Institute for the Science of Human History, the University of Tübingen, the National School of Anthropology and History in Mexico City, and the University ...

Rhesus macaque model offers route to study Zika brain pathology

June 21, 2018
Rhesus macaque monkeys infected in utero with Zika virus develop similar brain pathology to human infants, according to a report by researchers at the California National Primate Research Center and School of Veterinary Medicine ...

California Aedes mosquitoes capable of spreading Zika

June 21, 2018
Over the last five years, Zika virus has emerged as a significant global human health threat following outbreaks in South and Central America. Now, researchers reporting in PLOS Neglected Tropical Diseases have shown that ...

Breakthrough treatment for crippling jaw disease created

June 20, 2018
A first-ever tissue implant to safely treat a common jaw defect, known as temporomandibular joint dysfunction, has been successfully tested by UCI-led researchers in a large animal model, according to new findings.

New flu vaccine only a little better than traditional shot

June 20, 2018
A newer kind of flu vaccine only worked a little bit better in seniors this past winter than traditional shots, the government reported Wednesday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.